InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to ...

Shares of InMode (NASDAQ: INMD), a medical technology company focused on the aesthetics industry, recently reached a new 52-week high in anticipation of the second-quarter earnings report the company ...

InMode has a strong competitive position in the rapidly growing global aesthetic market with its innovative products and technology. The company has achieved impressive financial performance with ...

LAKE FOREST, Calif., Oct. 20, 2020 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, is pleased to introduce to the market the ...

InMode, known for radiofrequency microneedling technology in cosmetic applications, faces a blend of market opportunities and financial challenges. INMD's innovative products like Morpheus8 and Evolve ...

Sometimes the best opportunities are found in the laggards. Take medical technology (or medtech) stocks, for example. As a group, medtech stocks haven't performed well over the last year. However, ...

We recently compiled a list of the 10 Best Middle East and Africa Stocks To Buy According to Analysts. In this article, we are going to take a look at where InMode (NASDAQ:INMD) stands against the ...

InMode is a medical device maker that specializes in minimally invasive treatments with results that resemble those of liposuction. The average price target on Wall Street for InMode represents a 47% ...

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency ("RF") technology. InMode strives to enable ...

InMode Ltd INMD shares are trading lower by over 20% after the company issued Q3 guidance below estimates and lowered FY23 revenue guidance. The company expects Q3 revenue of $122.8 million-$123.0 ...

InMode Ltd INMD shares are trading lower Tuesday after the company reported better-than-expected results, but issued a weak earnings forecast. InMode noted that its proprietary surgical technology ...

Both InMode and Outset Medical have solid growth prospects. The main knock against Outset is that it isn't profitable yet, while InMode already generates strong profits. The better medtech stock to ...